Gastrointestinal Symptoms in 3181 Volunteers Ingesting Snack Foods Containing Olestra or Triglycerides for 6 Weeks
| Autor: | Dennis J. Lietz, Michael H. Brock, Mary G. Royer, Nora L. Zorich, Robert K. Miday, Heather B. Wiseman, Thomas G. Filloon, Robert S. Sandler |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Adult
Diarrhea Sucrose medicine.medical_specialty Olestra Adolescent Gastrointestinal Diseases Nausea medicine.medical_treatment Placebo-controlled study Placebo Dietary Fats Unsaturated Double-Blind Method Internal medicine Internal Medicine medicine Humans Ingestion Child Fat Substitutes Volunteer Triglycerides Aged Aged 80 and over business.industry Fat substitute Fatty Acids Infant General Medicine Placebo Effect Diet Records Abdominal Pain Surgery Food Child Preschool Defecation medicine.symptom business Constipation |
| Zdroj: | Annals of Internal Medicine. 130:253 |
| ISSN: | 0003-4819 |
| DOI: | 10.7326/0003-4819-130-4_part_1-199902160-00002 |
| Popis: | BACKGROUND: Olestra is a nonabsorbable, energy-free fat substitute. Because it is not absorbed, it may cause digestive symptoms when consumed in large amounts. OBJECTIVE: To compare the frequency and impact of gastrointestinal symptoms in adults and children who freely consume snacks containing olestra or regular snacks in the home. DESIGN: 6-week, double-blind, randomized, parallel, placebo-controlled trial. SETTING: General community. PARTICIPANTS: 3181 volunteers 2 to 89 years of age. INTERVENTION: Households received identical packages labeled as containing olestra corn or potato chips. These packages contained either olestra or regular chips (control). MEASUREMENT: Gastrointestinal symptoms and their impact on daily activities were reported in a daily record. RESULTS: At least one gastrointestinal symptom was reported by 619 of 1620 (38.2%) persons in the olestra group and 576 of 1561 (36.9%) controls (difference, 1.3 percentage points [95% CI, -3.6 to 6.2 percentage points]; P = 0.60). In general, the groups did not differ significantly in the proportion of participants who reported individual gastrointestinal symptoms; however, more controls reported nausea (8.4% compared with 5.7%; difference, -2.7 percentage points [CI, -4.9 to -0.4 percentage points]; P = 0.02). The only difference between groups for the mean numbers of days on which symptoms were reported was that participants in the olestra group had 1 more symptom-day of more frequent bowel movements than did controls (3.7 symptom-days compared with 2.8 symptom days; difference, 0.9 symptom-days [CI, 0.1 to 1.8 symptom-days]; P = 0.04). The groups did not differ in the impact of symptoms on daily activities. CONCLUSIONS: Clinically meaningful or bothersome gastrointestinal effects are not associated with unregulated consumption of olestra corn and potato chips in the home. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|